Template:Crofab indications
The following criteria for administration after Crotalidae bite allows for clinician judgment and shared decision making with the patient due to the extreme cost of Crofab[1]
- Progression of swelling
- Abnormal results on lab tests (plt < 100,000 or fibrinogen < 100)
- Systemic manifestations (unstable vitals or AMS)
- Neuromuscular toxicity
No studies show reduction in mortality from antivenom administration.
- ↑ Lavonas EJ et al: Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011; 11.